The customer received questionable elecsys ft4 ii assay results for one patient and suspected there was antibody interference as the ft4 result was very high with a normal tsh result.Multiple samples from the patient were tested on different analyzers.Of the data provided, the results for ft4, tsh, ft3, tpo, and total t4 were discrepant.Refer to the attachment to the medwatch for all patient data.The results were reported to the clinicians.The patient was not adversely affected.The reagent lot numbers and expiration dates were requested, but were not provided.A specific root cause could not be identified.The age of the only sample from the patient that was available for further investigation was past the stated stability of the analyte.From the information provided, a general reagent was not detected.
|
Investigation of the provided patient samples found an interfering factor to streptavidin was present.This interference is documented in product labeling for the assays.Additional assays were involved in the complaint.For these assays, the manufacturer fields were identical to the ft4, free thyroxine assay.For the tsh assay: elecsys tsh assay, radioimmunoassay, thyroid-stimulating hormone, jlw, catalog no: asku, lot #: 185522, expiration date: asku, k961491, udi: (b)(4).For the ft3 assay: elecsys ft3 iii, radioimmunoassay, total triiodothyronine, cdp, catalog no: asku, date: asku, exempt, udi: (b)(4).For the tpo assay: roche diagnostics cobas elecsys anti-tpo, system, test, thyroid autoantibody, jzo, catalog no: asku, lot #: asku, expiration date: asku, k051890, udi: (b)(4).For the t4 assay: elecsys t4 assay, radioimmunoassay, total thyroxine, cdx, catalog no: asku, lot #: asku, expiration date: asku, k961490, udi: (b)(4).
|